Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04088292 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism

Study acronym: STRATIFY
StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Oct 31, 2024 to Nov 30, 2024v6
  2. Trial status: Recruiting to Active, Not Recruiting
    • Secondary endpoints: 8 to 9
    • Site details revised at 4 of 4 sites
    v5
  3. Study sites: 3 to 4
    • Secondary endpoints: 9 to 8
    v4
  4. Primary completion date: Jun 5, 2023 to Jun 5, 2024
    • Study completion date: Oct 31, 2023 to Oct 31, 2024
    v3
  5. Primary completion date: Jun 5, 2021 to Jun 5, 2023
    • Study completion date: Oct 31, 2021 to Oct 31, 2023
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Open label clinical randomized trial comparing three strategies for managing acute intermediate-high risk pulmonary embolism
Trial Details
NCT Number NCT04088292
Lead Sponsor Copenhagen University Hospital, Rigshospitalet
Collaborators: Herlev and Gentofte Hospital, University Hospital Bispebjerg and Frederiksberg, Hillerod Hospital, Denmark, Copenhagen University Hospital, Hvidovre
Conditions
(from sponsor)		 Pulmonary Embolism
Related terms Pulmonary Embolism
Enrollment 210 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov